Valuation
26% of the score, 30% here after data gaps
0median 50
An operating loss over the last year: there are no earnings to price.
FLGTFulgent Genetics, Inc.
$20.87-7.8% 1Y
$20.87
$13.7952 weeks$30.85
RyuScore
Seven criteria, each scored 0 to 100 on a published scale, weighted into one number.
RyuScore 18 out of 100, Weak
Weak. Fulgent Genetics, Inc. scores higher than 21% of the 2,291 companies Ryufin scores.
Held back by valuation and return on new capital, with nothing carrying it far.
Healthcare median 18 · all companies 54
How the score has moved
At each fiscal year end, from the reports and price of the time39
35
18
18
202320242025today
The biggest move was down 17 points from 2024 to 2025, mostly return on capital.
Return on capital
18% of the score, 20% here after data gaps
55median 23
Over 7 years the business earned 10% a year after tax on the capital it uses.
2%
8%
15%
25%
10%
None at 2% or less, full points from 25%full points
7 years agolatest -11%
Return on new capital
16% of the score, 18% here after data gaps
0median 33
Over 6 years yearly profit fell by 159 cents for every dollar earned. New capital earned -223%, and 71% of profit went back into the business.
-5%
12%
-159%
None at minus 5 cents, full points from 12 centsfull points
Capital allocation
14% of the score, 16% here after data gaps
0median 63
How management spends the money: shares bought back or issued, and whether assets grow faster than the business they serve.
Share countUp 5.1% a year over 5 years: new shares
05%
-3%
5.1%
0 pointsfull points
Assets against salesAssets grew 12% a year, sales -5.2%
012%
-2%
17%
0 pointsfull points
Cycle position
Taken out: its 12% is shared by the others
n/ano data
Margins have been too thin to measure a cycle against.
Balance sheet
8% of the score, 9% here after data gaps
50median 50
What the debt weighs against the profit that has to carry it.
Net debt to EBITDAMore cash than debt
100Interest coverAn operating loss: the interest is not covered
01.5x
12x
-1019x
0 pointsfull points
Earnings quality
6% of the score, 7% here after data gaps
35median 90
Whether the reported profit arrives as cash, and whether the accounts show the usual signs of stretching.
AccrualsProfit ran ahead of cash by 3.4% of assets
358%
0%
-8%
3.4%
0 pointsfull points
How the RyuScore works
Each criterion earns 0 to 100 points on the scale drawn under it, and the RyuScore is their average weighted 26, 18, 16, 14, 12, 8 and 6. Scales bend in the company's favour between their ends, so an ordinary figure is never already near zero. For FLGT, cycle position could not be measured from the filings, so it is taken out and the remaining weights scale up.
Built from the company's annual and quarterly filings with the SEC and today's share price. Banks, insurers and property trusts are not scored: their debt is their raw material, so these yardsticks mean something else there. Figures as of 2026-06-30, latest annual report FY2025.
Diagnostics & Research
Ranks #14 of 21 by RyuScore